InventiGEL, a company specializing in long-acting injectable drugs and lipid nanoparticle (LNP) research, development, and manufacturing platforms, announced on the 16th that it has signed a memorandum of understanding (MOU) with the Korea Anti-Drug Movement Headquarters. Going forward, both parties will jointly cooperate to address the drug issues emerging as a social concern.


[Photo by Inventage Lab]

[Photo by Inventage Lab]

View original image

InventiGEL and the Korea Anti-Drug Movement Headquarters have agreed to raise social awareness about drugs and establish an integrated response system encompassing promotion, education, prevention, treatment, and rehabilitation. In particular, through this MOU, InventiGEL plans to develop products based on its long-acting injectable drug technology related to drug and alcohol addiction and collaborate to ensure practical treatment is realized.


InventiGEL is developing IVL-DrugFluidic, a microfluidics-based long-acting injectable drug manufacturing platform. Using this platform, the company has received approval from the Australian Human Research Ethics Committee (HREC) for a Phase 1 clinical trial application (IND) for the development of ‘IVL3004,’ a treatment for alcohol and drug addiction.


The global drug treatment market has been recording a steady growth rate of about 10% annually. Especially in South Korea, where recent drug use incidents involving famous celebrities and even minors’ exposure to drugs have caused serious social problems, InventiGEL aims to take the lead in solving these issues through rapid development of treatments.



Kim Joo-hee, CEO of InventiGEL, said, “As drug problems have become a major issue worldwide regardless of country, through this MOU with the Korea Anti-Drug Movement Headquarters, InventiGEL will strengthen its technology for developing long-acting treatments for drug and alcohol addiction and fulfill its corporate social responsibility.” CEO Kim was also appointed as a board member of the Korea Anti-Drug Movement Headquarters and plans to actively participate in establishing measures to eradicate drugs.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing